Related Experiment Video
Updated: Jun 15, 2026
15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
Towards a Brucella vaccine for humans.
Stuart D Perkins1, Sophie J Smither, Helen S Atkins
1Department of Biomedical Sciences, Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, UK.
FEMS Microbiology Reviews
|February 26, 2010
Summary
Human brucellosis vaccines are needed, as current animal vaccines are unsuitable. This review examines challenges and novel vaccine candidates for developing a safe and effective human brucellosis vaccine.
Area of Science:
- Infectious diseases and vaccinology.
- Microbiology and public health.
Background:
- Brucellosis is a significant zoonotic disease with no licensed human vaccine.
- Brucella species are common causes of laboratory-acquired infections and are CDC category B select agents.
- Existing animal vaccines are not suitable for human use due to safety concerns.
Purpose of the Study:
- To review the critical considerations for developing a human vaccine against brucellosis.
- To assess the current landscape of novel vaccine candidates for brucellosis.
Main Methods:
- Literature review of existing research on brucellosis vaccines.
- Analysis of challenges in vaccine development, including appropriate animal models.
- Evaluation of emerging vaccine technologies and candidate pipelines.
Main Results:
- Identified significant gaps in current human brucellosis vaccine development.
- Highlighted the limitations of existing animal vaccines for human application.
- Summarized the status and potential of several novel vaccine candidates.
Conclusions:
- Development of a safe and effective human brucellosis vaccine is a public health priority.
- Further research and development are crucial to advance promising vaccine candidates.
- Addressing specific challenges in animal modeling and clinical trials is essential for successful vaccine deployment.
Related Concept Videos
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
00:42Cross-reactivity
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...